TAK stock has results scheduled for October 29, 2026
Published on 10/26/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEarnings date and business focus
- Takeda's FY2026 second-quarter information is scheduled for October 29, 2026.
- Takeda develops medicines and vaccines through research and development.
- TAK was last quoted at USD 20.24 on October 23, 2026.
Takeda Pharmaceutical has scheduled the release of information for its FY2026 second quarter on October 29, 2026, according to the company's investor-relations website. Takeda also plans an investor, analyst and media webcast from 7:00 p.m. to 8:15 p.m. JST that day.
Upcoming earnings announcement
The October 29 release will cover Takeda's FY2026 second quarter. The webcast is scheduled for the same day and is intended for investors, analysts and media, according to Takeda's investor-relations website.
Takeda's business
Takeda develops medicines and vaccines through research and development focused on therapies for patients with limited or no treatment options. Its investor-relations materials describe a pipeline organized by development phase and therapeutic area. The company's next scheduled earnings announcement is October 29, 2026.
Market context: Market report S&P 500.
